SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2007-10-18
Filing Date Changed: 2007-10-19
Documents: 2
SEC Accession No.
0000812796-07-000081
Filing date: 2007-10-19
Accepted: 2007-10-19 15:30:37
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K fdapdufaletter.htm 17409 FDA PDUFA LETTER 10-18-07
2 EX-99.1 pressreleasepdufaletter.htm 24549 PRESS RELEASE PDUFA LETTER 10-18-07
0000812796-07-000081.txt 43650 Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 071181092
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200
 Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628